2013
DOI: 10.1074/jbc.m112.439422
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Mechanism of 17-Allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL Receptor Tyrosine Kinase Degradation

Abstract: Background: AXL is an established therapeutic target in various cancers. HSP90 chaperoning is critical in maintaining the stability of several oncogenic kinases. Results: HSP90 blockade by 17-AAG induced cytosolic mature AXL degradation via ubiquitin/proteasome pathway and impeded its membrane localization. Conclusion: AXL depends on HSP90 for its stability and membrane translocation. Significance: Targeting HSP90 would avail a strategy to counteract AXL.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
36
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(40 citation statements)
references
References 50 publications
2
36
0
Order By: Relevance
“…These bindings are crucial for cellular fate of NCC [38]. CHIP overexpression controls stability and promotes the degradation of several target proteins as the apoptosis suppressor (DDIAS), the potassium channel Kv1.5, the receptor tyrosine kinase AXL and several others [50-52]. We found here that overexpression of CHIP in MCD4 cells significantly decreased AQP2 abundance within one hour after CHX incubation.…”
Section: Discussionmentioning
confidence: 69%
See 1 more Smart Citation
“…These bindings are crucial for cellular fate of NCC [38]. CHIP overexpression controls stability and promotes the degradation of several target proteins as the apoptosis suppressor (DDIAS), the potassium channel Kv1.5, the receptor tyrosine kinase AXL and several others [50-52]. We found here that overexpression of CHIP in MCD4 cells significantly decreased AQP2 abundance within one hour after CHX incubation.…”
Section: Discussionmentioning
confidence: 69%
“…Client proteins of CHIP can be targeted either to lysosomes or to proteasomes for degradation [50, 54]. While short-chain ubiquitylation increases AQP2 endocytosis and lysosomal degradation [22], polyubiquitylation targets AQP2 to proteasomes, in fact MG132 treatment increased the stability of AQP2 by impairing its proteasomal degradation [23].…”
Section: Discussionmentioning
confidence: 99%
“…Geldanamycin elicits the Ub-dependent degradation of several metastable PM tyrosine receptor kinases (e.g., ErbB2, Ron, EGF, Met, and EphA2) as a consequence of the unfolding of their catalytic domains (72,129,153). Ubiquitination of these kinases is usually facilitated by the recruitment of the COOH terminus of Hsc70 interacting protein (CHIP) via Hsc70/Hsp70, which is upregulated upon Hsp90 inhibition as a consequence of cellular stress response (22).…”
Section: Cytoplasmic Domain Recognitionmentioning
confidence: 99%
“…Tumor cells are more dependent on Hsp90 than normal counterparts, and its pharmacological manipulation in order to interfere with the folding and conformational stability of client proteins has been shown to elicit their selective proteolytic degradation [21][22][23][24]. Cks proteins exist in twofolded states, a monomer or a domainswapped dimer, and are thought to interchange between these by way of folding intermediates [25].…”
Section: Introductionmentioning
confidence: 99%